Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$0.26
EPS est.
$0.22
EPS surprise
+18.18%
1-day move
+5.17%
Sotera Health's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 5.17% increase. However, the lack of revenue data and management commentary leaves some uncertainty about the company's overall performance and future direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.26 | N/A | +18.18% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Sotera Health Company operates in the health care sector, focusing on life sciences tools and services. The company plays a crucial role in providing essential services that support the health care industry, particularly in sterilization and contamination control.
Last quarter
In Q1-2026, Sotera Health reported an EPS of $0.18, beating expectations by 17.65%. However, the stock saw a slight decline of 0.39% the next day.
EPS beat streak
7Q
EPS beat rate
88%
Avg EPS surprise
+53.80%
Avg 1-day reaction
+2.08%
Investors are cautiously optimistic about Sotera Health's upcoming earnings, given its strong track record of beating EPS estimates.
Bull case
If Sotera continues its trend of exceeding EPS expectations, it could see a significant stock price increase, especially if revenue growth is also strong.
Bear case
Conversely, if the company fails to meet even its previous EPS performance, it could lead to a sharp decline in stock price, particularly given the high implied volatility in the options market.
The print will turn on these.
Q1
What will the EPS be for Q2-2026?
Given Sotera's history of beating EPS estimates, this number will be crucial in determining market sentiment.
Q2
How is revenue growth tracking compared to previous quarters?
Revenue growth is essential for assessing the company's overall health and future prospects.
—
Est. EPS
$3.08
Est. Rev
$7.2B
Impl. Move
±4.0%
Why consensus could be wrong
The market may underestimate Sotera's ability to sustain its earnings momentum, especially given its strong historical performance.
Supporting evidence
Sotera has consistently beaten EPS estimates, which may not be fully factored into current valuations.
The options market is pricing in a larger move than historical averages, indicating potential for a significant reaction.
The company's recent operational improvements may not be reflected in analyst expectations.
Key risk
If EPS comes in below $0.15, it could challenge the current optimistic outlook.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on whether Sotera can maintain its strong earnings trajectory amidst market challenges.
Bull confirmed if
An EPS of $0.20 or higher would confirm the bull case and indicate strong financial performance.
Bear confirmed if
An EPS below $0.15 would confirm the bear case and raise concerns about the company's profitability.
What the market is pricing for the move.
Implied Move
±17.26%
Historical Avg
±6.6%
The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.
Options are pricing ±17.3% while SHC has averaged ±6.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
24.5%
Smart-money positioning from the most recent 13F filings.
Institutional
106.03%
of float
Insider
2.40%
of float
Holders
411
institutions
Top Holders· as of Jun 2026
Sessa Capital IM, L.P.
27,050,000 sh · $484.2M
9.48%
17.3%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Sotera beats expectations, history suggests a potential stock increase of around 2.38%, confirming investor confidence.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future growth.
Miss
A miss could lead to a decline in stock price, with historical data suggesting a potential drop based on past performance.
The lines on the call that would change the story.
Darsana Capital Partners, LP
27,000,000 sh · $483.3M
9.46%
3.9%
Blackrock Inc.
24,148,424 sh · $432.3M
8.46%
15.8%
Sculptor Capital LP
24,000,000 sh · $429.6M
8.41%
10.5%
Sachem Head Capital Management, LP
15,560,000 sh · $278.5M
5.45%
33.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.